Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlobeImmune Inc (NASDAQ:GBIM)

2.08
Delayed Data
As of Jun 28
 0.00 / 0.00%
Today’s Change
0.72
Today|||52-Week Range
6.30
-46.25%
Year-to-Date
No recent news for GlobeImmune Inc.

Today’s Trading

Previous close2.08
Today’s open1.87
Day’s range1.87 - 2.09
Volume143,966
Average volume (3 months)520,931
Market cap$11.2M
Dividend yield--
Data as of 3:59pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+94.03%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+8.24%
P/E ratioNM
Price/Sales3.45
Price/Book3.73

Competitors

 Today’s
change
Today’s
% change
GBSNGreat Basin Scientif...+0.10+6.13%
APPYVenaxis Inc+0.01+0.31%
APHBAmpliPhi Biosciences...+0.04+2.65%
GALTUGalectin Therapeutic...0.000.00%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$6.5M
Annual profit (last year)-$2.8M
Net profit margin-42.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Timothy C. Rodell
Secretary, Treasurer &
Vice President-Finance
C. Jeffrey Dekker
Corporate headquarters
Louisville, Colorado

Forecasts

Partner Offers

Search for Jobs